IMCR – immunocore holdings plc - american depositary shares (US:NASDAQ)
Stock Stats
News
VectorY Therapeutics Appoints Kevin Pojasek, Ph.D., to Board of Directors
Immunocore (NASDAQ:IMCR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Levicept Announces the Appointment of James Sandy as Chief Development Officer [Yahoo! Finance]
Levicept Announces the Appointment of James Sandy as Chief Development Officer
Assessing Immunocore Holdings (IMCR) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Form 8-K Immunocore Holdings plc For: Jan 27
Form 8-K Immunocore Holdings plc For: Jan 09
Form 4 Immunocore Holdings plc For: Dec 04 Filed by: Berman David M
Form 4 Immunocore Holdings plc For: Nov 26 Filed by: Berman David M
Form 8-K Immunocore Holdings plc For: Nov 26
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.